References
- Kwon HL, Belanger K, Bracken MB. Asthma prevalence among pregnant and childbearing-aged women in the United States: Estimates from National Health Surveys. Ann Epidemiol 2003;13(5):317–24.
- Hansen C, Joski P, Freiman H, Andrade S, Toh S, Dublin S, et al. Medication Exposure in pregnancy risk evaluation program: The prevalence of asthma medication use during pregnancy. Matern Child Health J 2012;17(9):1611–21.
- Global Initiative for Asthma (GINA). From the Global Strategy for Asthma Management and Prevention [Internet]. 2016. Available from: http://www.ginasthma.org/ [last accessed July 2016]
- Charlton RA, Hutchison A, Davis KJ, de Vries CS. Asthma management in pregnancy. PLoS ONE 2013 Apr 4;8(4):e60247.
- Enriquez R, Wu P, Griffin MR, Gebretsadik T, Shintani A, Mitchel E, et al. Cessation of asthma medication in early pregnancy. Am J Obstet Gynecol 2006 Jul;195(1):149–53.
- Zetstra-van der Woude PA, Vroegop JS, Bos HJ, de Jong-van den Berg LTW. A population analysis of prescriptions for asthma medications during pregnancy. J Allergy Clin Immunol 2013;131(3):711–7.
- Alexander S, Dodds L, Armson BA. Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol 1998;92(3):435–40.
- Wen SW, Demissie K, Liu S. Adverse outcomes in pregnancies of asthmatic women: results from a Canadian population. Ann Epidemiol 2001;11(1):7–12.
- Enriquez R, Griffin MR, Carroll KN, Wu P, Cooper WO, Gebretsadik T, et al. Effect of maternal asthma and asthma control on pregnancy and perinatal outcomes. J Allergy Clin Immunol 2007;120(3):625–30.
- Rejnö G, Lundholm C, Gong T, Larsson K, Saltvedt S, Almqvist C. Asthma during pregnancy in a population-based study—Pregnancy complications and adverse perinatal outcomes. PLoS ONE 2014 Aug 20;9(8):e104755.
- Liu S, Wen SW, Demissie K, Marcoux S, Kramer MS. Maternal asthma and pregnancy outcomes: A retrospective cohort study. Am J Obstet Gynecol 2001;184(2):90–96.
- Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 2006;61(2):169–76.
- Murphy VE, Namazy JA, Powell H, Schatz M, Chambers C, Attia J, et al. A meta-analysis of adverse perinatal outcomes in women with asthma. BJOG Int J Obstet Gynaecol 2011;118(11):1314–23.
- Piette V, Demoly P. Asthme et grossesse: Revue des connaissances actuelles et prise en charge à la lumière des nouvelles recommandations GINA 2006. Rev Mal Respir 2009;26(4):359–79.
- Charlton RA, Pierini A, Klungsøyr K, Neville AJ, Jordan S, de Jong-van den Berg LTW, et al. Asthma medication prescribing before, during and after pregnancy: a study in seven European regions. BMJ Open 2016;6(1):e009237.
- Lacroix I, Hurault C, Sarramon MF, Guitard C, Berrebi A, Grau M, et al. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur J Clin Pharmacol 2009;65(8):839–46.
- Damase-Michel C, Lacroix I, Hurault-Delarue C, Beau A-B, Montastruc J-L, les partenaires d'EFEMERIS. [Drug in pregnancy: studies in the French database EFEMERIS]. Thérapie 2014;69(1):91–100.
- Sarkar M, Koren G, Kalra S, Ying A, Smorlesi C, Santis MD, et al. Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes. Eur J Clin Pharmacol 2009;65(12):1259–64.
- Bakhireva LN, Jones KL, Schatz M, Klonoff-Cohen HS, Johnson D, Slymen DJ, et al. Safety of leukotriene receptor antagonists in pregnancy. J Allergy Clin Immunol 2007;119(3):618–25.
- Kupryś-Lipińska I, Tworek D, Kuna P. Omalizumab in pregnant women treated due to severe asthma: two case reports of good outcomes of pregnancies. Adv Dermatol Allergol Dermatol Alergol 2014;31(2):104–7.
- Namazy J, Cabana MD, Scheuerle AE, Thorp Jr. JM, Chen H, Carrigan G, et al. The Xolair Pregnancy Registry (EXPECT): The safety of omalizumab use during pregnancy. J Allergy Clin Immunol 2015;135(2):407–12.
- Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES). Recommandations pour le suivi médical des patients asthmatiques adultes et adolescents [Internet]. 2004. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/recommandations_asthme.pdf [last accessed July 2016]
- Association Mieux Prescrire (Ed.). Drugs to avoid during pregnancy: omalizumab and montelukast, too many uncertainties. Prescrire Int 2014;23(146):51.
- Kim S, Kim J, Park SY, Um H-Y, Kim K, Kim Y, et al. Effect of pregnancy in asthma on health care use and perinatal outcomes. J Allergy Clin Immunol 2015;136(5):1215–23.e6.